tiprankstipranks
Trending News
More News >
Editas Medicine Inc (EDIT)
NASDAQ:EDIT
US Market

Editas Medicine (EDIT) Financial Statements

Compare
3,558 Followers

Editas Medicine Financial Overview

Editas Medicine's market cap is currently $238.81M. The company's EPS TTM is $-0.06; its P/E ratio is -8.09; Editas Medicine is scheduled to report earnings on March 9, 2026, and the estimated EPS forecast is $-0.27. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 40.52M$ 32.31M$ 78.12M$ 19.71M$ 25.54M
Gross Profit$ 35.24M$ 32.31M$ 72.06M$ 13.38M$ 20.49M
Operating Income$ -99.34M$ -251.15M$ -169.18M$ -225.95M$ -193.15M
EBITDA$ -94.06M$ -233.11M$ -163.12M$ -219.61M$ -188.09M
Net Income$ -160.06M$ -237.09M$ -153.22M$ -220.43M$ -192.50M
Balance Sheet
Cash & Short-Term Investments$ 146.65M$ 269.91M$ 323.11M$ 344.27M$ 499.85M
Total Assets$ 186.53M$ 341.59M$ 499.15M$ 514.32M$ 677.48M
Total Debt$ 76.71M$ 35.03M$ 48.54M$ 43.95M$ 26.38M
Net Debt$ -69.94M$ -96.51M$ -75.11M$ -97.58M$ -177.14M
Total Liabilities$ 159.25M$ 207.31M$ 150.06M$ 153.64M$ 123.84M
Stockholders' Equity$ 27.29M$ 134.27M$ 349.10M$ 360.68M$ 553.64M
Cash Flow
Free Cash Flow$ -165.85M$ -219.11M$ -136.90M$ -181.47M$ -171.78M
Operating Cash Flow$ -165.24M$ -210.28M$ -132.18M$ -177.35M$ -163.80M
Investing Cash Flow$ 138.67M$ 162.15M$ -3.73M$ 114.07M$ -54.47M
Financing Cash Flow$ 40.47M$ 56.03M$ 118.04M$ 1.28M$ 282.11M
Currency in USD

Editas Medicine Earnings and Revenue History

Editas Medicine Debt to Assets

Editas Medicine Cash Flow

Editas Medicine Forecast EPS vs Actual EPS